摘要
目的:了解中国风湿免疫病(rheumatic diseases,RD)患者活动性结核病(active tuberculosis,ATB)的患病情况。方法:采用分层多阶段整群抽样方法,纳入2014年9月至2016年3月期间,来自全国东、中、西部13家三级甲等综合医院的进行ATB筛查的RD患者作为调查对象,共计13550例。估算RD患者的ATB患病率,并按照RD病种、患者年龄和性别进行亚组分析。结果:13550例调查对象中,105例合并ATB,其中,48例(45.7%)无咳嗽、咳痰、发热、盗汗、体质量减轻表现;在病原学和(或)组织病理学确诊的ATB患者中,无症状者占35.3%(12/34);在菌阳肺结核患者中,无症状者占30.8%(8/26)。累及肺外部位的结核病有41例(39.0%),其中单纯肺外结核28例(68.3%),肺结核合并肺外结核13例(31.7%)。亚组分析结果显示,系统性血管炎综合征患者ATB患病率最高,为1915/10万(13/679,95%CI:881/10万~2948/10万),其次为弥漫性结缔组织病患者(1002/10万,58/5789,95%CI:745/10万~1259/10万)。RD患者中16~34岁组ATB患病率最高,为1162/10万(43/3700,95%CI:817/10万~1508/10万),男性ATB患病率为919/10万(30/3264,95%CI:592/10万~1247/10万),明显高于女性(729/10万,75/10286,95%CI:565/10万~894/10万)。结论:中国RD患者中亚临床结核病、肺外结核及结核病播散负担较高,ATB患病率在不同RD患者病种、年龄、性别间存在明显差异。
Objective:This study aimed to investigate the prevalence of active tuberculosis(ATB)among patients with rheumatic diseases(RD)in China.Methods:Using a stratified multi-stage cluster sampling method,a total of 13550 RD patients who underwent ATB screening from 13 tertiary hospitals in the eastern,central,and western regions of China between September 2014 and March 2016 were included in the survey.Participants underwent screening for ATB,and the prevalence of ATB was calculated.Subgroup analyses were performed based on RD subtype,age,and sex.Results:Among the 13550 surveyed subjects,105 case diagnosed with ATB,48(45.7%)exhibited no classical symptoms such as cough,sputum production,fever,night sweats,or weight loss.Of those with microbiological and/or pathological confirmation of ATB,35.3%(12/34)were asymptomatic,while the asymptomatic rate was 30.8%(8/26)among patients with bacteriologically confirmed pulmonary tuberculosis(PTB).Extrapulmonary tuberculosis(EPTB)was identified in 41 cases(39.0%),with 28 cases(68.3%)being exclusively EPTB and 13 cases(31.7%)involving combined pulmonary and extrapulmonary disease.The highest prevalence of ATB was observed in patients with systemic vasculitis syndrome,reaching 1915/100000(13/679;95%CI:881/100000-2948/100000),followed by patients with diffuse connective tissue diseases,at 1002/100000(58/5789;95%CI:745/100000-1259/100000).Among RD patients,the 16-34 age group exhibited the highest ATB prevalence,recorded at 1162/100000(43/3700;95%CI:817/100000-1508/100000).Males demonstrated a higher prevalence(919/100000,30/3264;95%CI:592/100000-1247/100000)compared to females(729/100000,75/10286;95%CI:565/100000-894/100000).Conclusion:Patients with RD in China carry a substantial burden of subclinical TB,EPTB,and disseminated TB.The prevalence of ATB shows marked differences across RD subtypes,age groups,and genders.
作者
张丽帆
陈艳
张月秋
张奉春
曾小峰
赵岩
刘升云
左晓霞
张志毅
吴华香
陈盛
李鸿斌
朱平
武丽君
齐文成
刘毅
张缪佳
刘花香
周宝桐
侍效春
阮桂仁
刘晓清
中国风湿免疫病人群活动性结核病的流行病学调查和治疗效果及预后研究课题组
Zhang Lifan;Chen Yan;Zhang Yueqiu;Zhang Fengchun;Zeng Xiaofeng;Zhao Yan;Liu Shengyun;Zuo Xiaoxia;Zhang Zhiyi;Wu Huaxiang;Chen Sheng;Li Hongbin;Zhu Ping;Wu Lijun;Qi Wencheng;Liu Yi;Zhang Miaojia;Liu Huaxiang;Zhou Baotong;Shi Xiaochun;Ruan Guiren;Liu Xiaoqing;The Epidemiological Study and Therapeutic Evaluation of Rheumatic Patients with Tuberculosis Study Team(Division of Infectious Diseases,Department of Internal Medicine,State Key Laboratory of Complex Severe and Rare Disease,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100730,China;Clinical Epidemiology Unit,International Epidemiology Network,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100730,China;Centre for Tuberculosis Research,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100730,China;Department of Rheumatology and Clinical Immunology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,National Clinical Research Center for Dermatologic and Immunologic Diseases,State Key Laboratory of Complex Severe and Rare Disease,Key Laboratory of Rheumatology and Clinical Immunology,Ministry of Education,Beijing 100730,China;Department of Rheumatology and Immunology,The First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;Department of Rheumatology and Immunology,Xiangya Hospital,Central South University,Changsha 410008,China;Department of Rheumatology and Immunology,The First Affiliated Hospital of Harbin Medical University,Harbin 150001,China;Department of Rheumatology,The Second Affiliated Hospital of Zhejiang University School of Medicine,Hangzhou 310009,China;Department of Rheumatology,Renji Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai 200001,China;Department of Rheumatology and Immunology,The Affiliated Hospital of Inner Mongolia Medical University,Hohhot 010000,China;Department of Clinical Immunology,Xijing Hospital,Fourth Military Medical University,Xi’an 710032,China;Department of Rheumatology,People’s Hospital of Xinjiang Uygur Autonomous Region,Urumqi 830001,China;Department of Rheumatology,Tianjin First Central Hospital,Tianjin 300192,China;Department of Rheumatology and Immunology,West China Hospital,Sichuan University,Chengdu 610041,China;Department of Rheumatology,The First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China;Department of Rheumatology,Qilu Hospital of Shandong University,Ji’nan 250012,China;不详)
出处
《中国防痨杂志》
CAS
北大核心
2025年第1期22-28,共7页
Chinese Journal of Antituberculosis
基金
国家科技重大专项(2014ZX10003003)
中央高水平医院临床科研专项(2022-PUMCH-A-119
2022-PUMCH-C-013)
国家自然科学基金面上项目(82373648)。
关键词
结核
风湿性疾病
共病现象
患病率
横断面研究
Tuberculosis
Rheumatic diseases
Comorbidities
Prevalence
Cross-sectional studies